Omega Cardioprotector
En vente sur le marché américain (selon le DSLD)
Thrivous, food supplement from the US market
Omega Cardioprotector (Thrivous), a food supplement au code-barres 866033000253, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Thrivous
- Barcode
- 866033000253
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 4 servings per day
- Other ingredients (in English, as written)
- Cellulose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Omega 3 Lysine Complex | Fatty acid | 556 mg |
| Garlic bulb extract (Allium sativum) | Plant | 300 mg |
| Centella asiatica extract (Centella asiatica) | Plant | 60 mg |
| French Maritime Pine bark extract (Pinus pinaster) | Plant | 50 mg |
| Olive leaf extract | Plant | 40 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Omega Cardioprotector
Entered into DSLD on 23 August 2019. Retirée du marché américain le 29 April 2021 (selon le DSLD).- Active ingredient added : Docosahexaenoic Acid (200 mg)
- Active ingredient added : Omega-3 Fatty Acids (300 mg)
- Active ingredient removed : Centella asiatica extract (60 mg)
- Active ingredient removed : Olive leaf extract (40 mg)
- Active ingredient removed : Omega 3 Lysine Complex (556 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Garlic bulb extract
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Thrivous
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.